Assembly Biosciences (ASMB) Short-term Investments (2015 - 2026)

Assembly Biosciences' Short-term Investments history runs 12 years deep, the most recent figure standing at $195.5 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 189.11% year-over-year to $195.5 million; the TTM figure through Mar 2026 stood at $195.5 million (up 189.11% YoY), while the FY2025 annual figure was $189.7 million, up 157.21% from the prior year.
• Short-term Investments was $195.5 million for Q1 2026 at Assembly Biosciences, up from $189.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $210.0 million in Q3 2025 to a low of $19.6 million in Q3 2023.
• Historically, Short-term Investments has averaged $86.7 million across 5 years, with a median of $71.8 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments sank 63.77% in 2023, then surged 240.09% in 2024.
• A 5-year view of Short-term Investments shows it stood at $39.2 million in 2022, then jumped by 181.71% to $110.4 million in 2023, then plunged by 33.21% to $73.7 million in 2024, then jumped by 157.21% to $189.7 million in 2025, then increased by 3.07% to $195.5 million in 2026.
• The last three Short-term Investments figures came in at $195.5 million (Q1 2026), $189.7 million (Q4 2025), and $210.0 million (Q3 2025), per Business Quant data.